Based on our perfused liver and neural tissue models, in collaboration with biotechnology/pharmaceutical and academic partners, we are currently validating the following applications:

• Human cholestasis model
• Drug metabolism assay for low-clearance (24-72h half-life) compounds
• DILI assay
• Human chronic epilepsy model
• Neurotoxicity assays